New Lancet report suggest Homoeopathy over conventional medicine in Cancer treatment

New Lancet report says that Homoeopathy over conventional medicine in Cancer treatment – the number of people opting Homoeopath for cancer treatment is on the rise.

Lancet report published in January, 2019 – Cancer patients intended to use homeopathy as a complement to standard cancer treatment (83; 38%), rejected standard treatment (63; 29%), or could not afford/accommodate standard therapy (69; 31%).

In the current study, the investigators report that about a third of the campaigns (63; 29%) made positive claims about the activity of homeopathy for cancer.

It is estimated that approximately half of all patients with cancer use complementary and alternative medicine (CAM), and its popularity is on the rise

A June 2018 analysis of the crowdfunding platform GoFundMe identified 220 unique campaigns for cancer patients seeking financial support for homeopathy.

The vast majority (186; 85%) of the campaigners were in the United States, with some in Canada (23; 10%) and the United Kingdom (8; 4%), and just one campaign each in Germany, Ireland, and Spain.

The campaigns requested US $5.8 million and were pledged US $1.4 million (24% of the total requested amount) by 13,621 donors.

There are three outstanding reasons that this group of 200-plus cancer patients turned to homeopathy, report the study authors, led by Jeremy Snyder, PhD, of Simon Fraser University, Burnaby, British Columbia, Canada.

Read full paper 


  1. Homoeopathy offers rapid gentle and permanent restoration of health in a very harmless way, Something very important in the treatment of cancer.

  2. Cancer can be treated with homoeopathy,with a great force than any other party , homoeopathy deals with genetics of cell ,so it has power to reverse the condition or Pathology of cancer or any incurable Pathology , so homoeopathy is always best than treating disease or Pathology locally through chemicals or allopathic medicine.

Leave a Reply

Your email address will not be published.